Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013084498> ?p ?o ?g. }
- W2013084498 endingPage "1187" @default.
- W2013084498 startingPage "1179" @default.
- W2013084498 abstract "Psychiatric disorders and medications may affect the cognitive performance of patients with cirrhosis and complicate the diagnosis and prediction of hepatic encephalopathy (HE). The aim of this study was to study the association of psychoactive medications with cognitive performance and their effects on the ability of tests to predict HE development in patients with cirrhosis referred for transplant evaluation. Cirrhosis details, psychiatric disorders, psychoactive medications, and any history of prior HE were recorded for patients with cirrhosis at 2 transplant centers. Patients were followed until the development of HE. Five cognitive tests--number connection test A (NCT-A), number connection test B, the digit symbol test (DST), the block design test, and the inhibitory control test (ICT)--were administered. A high lure score and a low ICT target score indicated poor performance. The cognitive performances of patients with psychiatric disorders/medications and patients without them were compared. A proportional hazards model was created with the time to HE as the outcome, and it was based on demographics, psychoactive medications, cirrhosis details, and individual cognitive scores. Patients with prior HE and patients without prior HE were then studied separately. One hundred fifty-five patients with a mean age of 57.5 ± 6.2 years and a mean Model for End-Stage Liver Disease (MELD) score of 15.1 ± 6.2 were included [prior HE, 48%; diabetes, 34%; selective serotonin reuptake inhibitors (SSRIs), 32%; opioids, 19%; and antipsychotics, 10%]. Prior HE and antipsychotics (but not opioids or diabetes) were associated with worse cognition. SSRI users had better NCT-A and DST performance. One hundred forty-eight patients were followed for a median of 182.5 days; 58 developed HE at a median of 99 days after inclusion. In the entire group, the model showed that prior HE (hazard ratio = 4.13), the MELD score (hazard ratio = 1.07), and a high lure score (hazard ratio = 1.04) decreased the time to HE, whereas the use of SSRIs (hazard ratio = 0.42), a high target score (hazard ratio = 0.95), and a high sodium level (hazard ratio = 0.89) increased the time to HE. For patients without prior HE, the MELD score (hazard ratio = 1.25) and lures (hazard ratio = 1.09) predicted the time to HE. Lures (hazard ratio = 1.03), targets (hazard ratio = 0.96), and sodium (hazard ratio = 0.87) were associated with the time to HE in patients with prior HE. In conclusion, cognitive tests (particularly the ICT) remain valid predictors of HE in the face of psychiatric diseases and medications. SSRI use is associated with better cognitive performance and a reduced likelihood of developing HE." @default.
- W2013084498 created "2016-06-24" @default.
- W2013084498 creator A5012827359 @default.
- W2013084498 creator A5018022782 @default.
- W2013084498 creator A5048453227 @default.
- W2013084498 creator A5053115833 @default.
- W2013084498 creator A5062214751 @default.
- W2013084498 creator A5067770887 @default.
- W2013084498 creator A5069307755 @default.
- W2013084498 creator A5070639714 @default.
- W2013084498 creator A5085461623 @default.
- W2013084498 creator A5087286473 @default.
- W2013084498 date "2012-10-01" @default.
- W2013084498 modified "2023-09-23" @default.
- W2013084498 title "Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: A prospective study" @default.
- W2013084498 cites W1479841946 @default.
- W2013084498 cites W1486067581 @default.
- W2013084498 cites W1584844609 @default.
- W2013084498 cites W1966724162 @default.
- W2013084498 cites W1967235520 @default.
- W2013084498 cites W1968750085 @default.
- W2013084498 cites W1969189353 @default.
- W2013084498 cites W1973661816 @default.
- W2013084498 cites W1975615075 @default.
- W2013084498 cites W1978119032 @default.
- W2013084498 cites W1980227056 @default.
- W2013084498 cites W1982049192 @default.
- W2013084498 cites W1983700957 @default.
- W2013084498 cites W1985129563 @default.
- W2013084498 cites W1986818508 @default.
- W2013084498 cites W1999336665 @default.
- W2013084498 cites W2004311396 @default.
- W2013084498 cites W2005025961 @default.
- W2013084498 cites W2012345707 @default.
- W2013084498 cites W2025789176 @default.
- W2013084498 cites W2026283872 @default.
- W2013084498 cites W2026352845 @default.
- W2013084498 cites W2033192386 @default.
- W2013084498 cites W2033593147 @default.
- W2013084498 cites W2037304868 @default.
- W2013084498 cites W2039230224 @default.
- W2013084498 cites W2045238849 @default.
- W2013084498 cites W2048727161 @default.
- W2013084498 cites W2072139861 @default.
- W2013084498 cites W2074040512 @default.
- W2013084498 cites W2079385693 @default.
- W2013084498 cites W2079703851 @default.
- W2013084498 cites W2083754290 @default.
- W2013084498 cites W2094712133 @default.
- W2013084498 cites W2115235249 @default.
- W2013084498 cites W2115378686 @default.
- W2013084498 cites W2123091375 @default.
- W2013084498 cites W2123986082 @default.
- W2013084498 cites W2132348584 @default.
- W2013084498 cites W2133296221 @default.
- W2013084498 cites W2141714965 @default.
- W2013084498 cites W2143814803 @default.
- W2013084498 cites W2146276801 @default.
- W2013084498 doi "https://doi.org/10.1002/lt.23484" @default.
- W2013084498 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3604696" @default.
- W2013084498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22674517" @default.
- W2013084498 hasPublicationYear "2012" @default.
- W2013084498 type Work @default.
- W2013084498 sameAs 2013084498 @default.
- W2013084498 citedByCount "27" @default.
- W2013084498 countsByYear W20130844982014 @default.
- W2013084498 countsByYear W20130844982016 @default.
- W2013084498 countsByYear W20130844982018 @default.
- W2013084498 countsByYear W20130844982019 @default.
- W2013084498 countsByYear W20130844982020 @default.
- W2013084498 countsByYear W20130844982021 @default.
- W2013084498 countsByYear W20130844982022 @default.
- W2013084498 crossrefType "journal-article" @default.
- W2013084498 hasAuthorship W2013084498A5012827359 @default.
- W2013084498 hasAuthorship W2013084498A5018022782 @default.
- W2013084498 hasAuthorship W2013084498A5048453227 @default.
- W2013084498 hasAuthorship W2013084498A5053115833 @default.
- W2013084498 hasAuthorship W2013084498A5062214751 @default.
- W2013084498 hasAuthorship W2013084498A5067770887 @default.
- W2013084498 hasAuthorship W2013084498A5069307755 @default.
- W2013084498 hasAuthorship W2013084498A5070639714 @default.
- W2013084498 hasAuthorship W2013084498A5085461623 @default.
- W2013084498 hasAuthorship W2013084498A5087286473 @default.
- W2013084498 hasBestOaLocation W20130844981 @default.
- W2013084498 hasConcept C118552586 @default.
- W2013084498 hasConcept C126322002 @default.
- W2013084498 hasConcept C14216870 @default.
- W2013084498 hasConcept C169900460 @default.
- W2013084498 hasConcept C185711340 @default.
- W2013084498 hasConcept C2777214474 @default.
- W2013084498 hasConcept C2778355293 @default.
- W2013084498 hasConcept C2779609443 @default.
- W2013084498 hasConcept C2780325230 @default.
- W2013084498 hasConcept C2911091166 @default.
- W2013084498 hasConcept C71924100 @default.
- W2013084498 hasConceptScore W2013084498C118552586 @default.
- W2013084498 hasConceptScore W2013084498C126322002 @default.
- W2013084498 hasConceptScore W2013084498C14216870 @default.